[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369229-105":59,"doc-detail-369229-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pan-cancer-analysis-reveals-smarcal1-expression-is-associated-with-immune-cell-infiltration-and-poor-prognosis-in-various-cancers","Pan-cancer analysis reveals SMARCAL1 expression is associated with immune cell infiltration and poor prognosis in various cancers","","Pan-cancer analysis examines whether SMARCAL1 contributes to tumor immune evasion and clinical outcomes. Using TCGA, GTEx, and CCLE, the study evaluates SMARCAL1 expression, genetic alterations, epigenetic modifications, and clinical correlations across 33 cancer types. SMARCAL1 is overexpressed in cancers including glioma, LUAD, KIRC, and LIHC, with elevated levels linked to poor prognosis in glioma, LUAD, and LIHC. Associations with DNA methylation in 13 cancers and immune infiltration support SMARCAL1 as a potential immunotherapy target.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pan-cancer-analysis-reveals-smarcal1-expression-is-associated-with-immune-cell-infiltration-and-poor-prognosis-in-various-cancers/369229/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pan-cancer-analysis-reveals-smarcal1-expression-is-associated-with-immune-cell-infiltration-and-poor-prognosis-in-various-cancers/369229.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the purpose of this pan-cancer study on SMARCAL1?","Question",{"text":112,"@type":113},"To characterize SMARCAL1 expression across cancers, determine its prognostic value, and evaluate its relationship with immunotherapy and immune-related functions.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which databases were used to analyze SMARCAL1 in multiple cancer types?",{"text":117,"@type":113},"SMARCAL1 was analyzed using TCGA, GTEx, and CCLE, with additional protein expression context from the Human Protein Atlas and datasets for expression profiles from CCLE and UCSC Xena.",{"name":119,"@type":110,"acceptedAnswer":120},"How is SMARCAL1 expression linked to outcomes and immune infiltration?",{"text":121,"@type":113},"SMARCAL1 overexpression is associated with poor prognosis in several cancers, and its expression correlates with immune infiltration, suggesting a role in tumor immune evasion and potential therapeutic targeting.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369229,1790210847,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nPan-cancer analysis reveals SMARCAL1 expression is associated with immune cell infiltration and poor prognosis in various cancers  \nWu-jie Zhao1,6, Meng-lei Wang2,6, Yun-fang Zhao3,6, Wen-peng Zhao1, Qiong-hui Huang4, Zhen-wei Lu4, Fang Jia5, Jin-jin Shi1, Bo-sen Liu1, Wan-hong Han1, Han-wen Lu1,  \nBing-chang Zhang1􀀍 & Zhan-xiang Wang1􀀍  \nAlthough immune checkpoint inhibition in particular has shown promise in cancer immunotherapy, it isnot always efficient. Recent studies suggest that SMARCAL1 may play a role in tumor immune evasion, yet its pan-cancer role is unclear. We conducted a comprehensive analysis ofSMARCAL1 using TCGA, GTEx, and CCLE databases, evaluating its expression, genetic alterations, epigenetic modifications, and their clinical correlations across 33 cancer types. Our findings indicate that SMARCAL1 is overexpressed in several cancers, such as Glioma, LUAD, KIRC, and LIHC, impacting prognosis. Elevated SMARCAL1 is linked to poor outcomes in Glioma, LUAD, and LIHC but correlates with better survival in KIRC. We also found significant associations between SMARCAL1 expression and DNA methylation in 13 cancers. Furthermore, SMARCAL1 expression correlates with immune infiltration, suggesting it as a potential therapeutic target in cancer immunotherapy. This study underscores the need for further research on SMARCAL1 to enhance immunotherapeutic strategies.  \nKeywords SMARCAL1, Pan-cancer, Glioma, Immunotherapy, Integrative analysis  \nCancer continues to be the world’s greatest cause of death, posing serious threats to life expectancy and public health. Patients suffer significant physical and financial consequences from cancer, and recent research has shown that the prevalence and death of cancer are quickly rising globally1,2. The five-year survival rate is still poor despite attempts to enhance clinical outcomes and quality of life, leading to the need for the investigation of innovative treatment approaches3,4.  \nImmunotherapy, utilizing drugs targeting immune checkpoint genes (ICGs), has emerged as a critical approach to cancer treatment. Immune checkpoint inhibitors, such as those targeting PD-1 or PD-L1, have shown efficacy in the treatment of advanced melanoma by inhibiting pathways that shield tumor cells from immune system attack5,6. Even while immunotherapy can cause long-lasting remissions in a variety of cancer types, many people still do not benefit from it7. Therefore, there is a pressing need for alternative strategies to enhance its efficacy8,9.  \nRecent targeted screening efforts have identified the DNA translocase SMARCAL1 as a factor inhibiting the immune response of tumor cells due to its dual role in restricting innate immune signaling and upregulating PD-L1 levels10. SMARCAL1 functions as a DNA helicase, playing a crucial role in DNA replication and repair processes. It unwinds DNA double strands, facilitating DNA rearrangement and repair11. The function of SMARCAL1 is essential for maintaining genome stability and preventing DNA damage12. Aberrant SMARCAL1  \n1Department of Neurosurgery and Department of Neuroscience, Fujian Key Laboratory of Brain Tumors Diagnosis and Precision Treatment, Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361005, Fujian, China. 2Department of Digestive Diseases, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361005, Fujian, China.  \n3Jitang College of North China University of Science and Technology, Tangshan 063000, Hebei, China. 4The School of Clinical Medicine, Fujian Medical University, Fuzhou 350108, Fujian, China. 5Department of Neurosurgery, The Third Affiliated Hospital of SunYat-Sen University, Guangzhou 510630, Guangdong, China. 6Wu-jie Zhao, Meng-lei Wang andYun-fang Zhao contributed equally to this study. 􀀍 email: [bczhang@xmu.edu.c","cbCairNomXsnYwuS","https://ap.wps.com/l/cbCairNomXsnYwuS","pdf",20999598,"English","# Introduction\n## Rationale for SMARCAL1 in cancer immunotherapy\n# Methods\n## Expression and subcellular localization analysis\n## Prognostic assessment in pan-cancer","[{\"question\":\"What is the purpose of this pan-cancer study on SMARCAL1?\",\"answer\":\"To characterize SMARCAL1 expression across cancers, determine its prognostic value, and evaluate its relationship with immunotherapy and immune-related functions.\"},{\"question\":\"Which databases were used to analyze SMARCAL1 in multiple cancer types?\",\"answer\":\"SMARCAL1 was analyzed using TCGA, GTEx, and CCLE, with additional protein expression context from the Human Protein Atlas and datasets for expression profiles from CCLE and UCSC Xena.\"},{\"question\":\"How is SMARCAL1 expression linked to outcomes and immune infiltration?\",\"answer\":\"SMARCAL1 overexpression is associated with poor prognosis in several cancers, and its expression correlates with immune infiltration, suggesting a role in tumor immune evasion and potential therapeutic targeting.\"}]","Pan-cancer analysis reveals SMARCAL1 expression is associated with immune cell infiltration and poor prognosis in various cancers | PDF",1790181512,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bbcfdf1e48c737e825775ec1e3f37bd9.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/379974d055b61dc7da456b6c6107b9d5.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8ddb1190826b408a2f5a4d0225ca999.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff138a48da0ed2f39417733ccc77f895.webp",980,1287]